Comparative study of the possible protective effects of cinnamic acid and cinnamaldehyde on cisplatin-induced nephrotoxicity in rats

Journal of Biochemical and Molecular Toxicology

Volumn 27, Issue 12, 2013, Pages 508-514

  El Sayed, El Sayed M ^a   Abd El Raouf, Ola M ^b   Fawzy, Hala M ^b   Manie, Mohamed F ^b  

^a Al Azhar University   (Egypt)

^b NATIONAL ORGANIZATION FOR DRUG CONTROL AND RESEARCH NODCAR   (Egypt)

Author keywords

Anti Oxidant; Cinnamaldehyde; Cinnamic Acid; Cisplatin; Nephrotoxicity

Indexed keywords

CATALASE; CINNAMALDEHYDE; CINNAMIC ACID; CISPLATIN; CREATININE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDE; MALONALDEHYDE; SERUM ALBUMIN; SUPEROXIDE DISMUTASE; UREA;

ADULT; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; AUTOPSY; BODY WEIGHT; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY MASS; MALE; NEPHROTOXICITY; NONHUMAN; RAT; RENAL PROTECTION; SINGLE DRUG DOSE; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

RATTUS;

ANTI-OXIDANT; CINNAMALDEHYDE; CINNAMIC ACID; CISPLATIN; NEPHROTOXICITY;

ACROLEIN; ALBUMINS; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BLOOD UREA NITROGEN; CINNAMATES; CISPLATIN; CREATININE; KIDNEY; KIDNEY DISEASES; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84897071593     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21515     Document Type: Article

References (46)

1. Badary O, Abdel-Maksoud S, Ahmed W, Owieda G. Naringenin attenuates cisplatin nephrotoxicity in rats. Life Sci 2005;76:2125-2135.
2. Rabik CA, Dolan ME. Molecular mechanisms and toxicity associated with platinating agents. Cancer Treat Rev 2007;33:9-23.
3. Schrier RW. Cancer therapy and renal injury. J Clin Invest 2002;100:743-745.
4. Lebwohl D, Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 1998;34:1522-1534.
5. Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol 2003;23:460-464.
6. Luke DR, Vadiel K, Lopez-BeresteinG Role of vascular congestion in cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 1992;7:1-7.
7. Ramesh G, Reeves WB. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 2003;285:F610-F618.
8. Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008;73:994-1007.
9. Chirino Y, Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 2009;61:223-242.
10. Tsuruya K, Tokumoto M, Ninomiya T, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Hirakata H, Iida M. Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor mediated pathways. Am J Physiol Renal Physiol 2003;285:F208-F218.
11. Weijl NI, Elsendoorn TJ, Lentjes EG, Hopman GD, Wipkin-Bakker A, Zwinderman AH, Cleton FJ, Osanto S. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised double blind placebo-controlled study. Eur J Cancer 2004;40:1713-1723.
12. Dickey DT, Wu YJ, Muldoon LL, Neuwelt EA. Protection against cisplatin-induced toxicities by N-acetyl cysteine and sodium thiosulfate as assessed at the molecular cellular and in vivo levels. J Pharmacol Exp Ther 2005;314:1052-1058.
13. Gulec M, Iraz M, Yilmaz HR, Ozyurt H, Temel I. The effects of Ginkgo biloba extract on tissue adenosine deaminase, xanthine oxidase, myeloperoxidase, malondialdehyde and nitric oxide in cisplatin-induced nephrotoxicity. Toxicol Ind Health 2006;22:125-130.
14. Basinger MA, Jones MM, Holscher MA. L-methionine antagonism of cis-platinum nephrotoxicity. Toxicol Appl Pharmacol 1990;103(1):1-15.
15. Appenroth D, Frob S, Kersten L, Splinter FK, Winnefeld K. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol 1997;71(11):677-683.
16. Somani SM, Husain K, Whitworth C, Trammell GL, Malafa M, Rybak LP. Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: Antioxidant defense system. Pharmacol Toxicol 2000;86(5):234-241.
17. El-Sayed EM, Abd-Ellah MF, Attia SM. Protective effect of captopril against cisplatin-induced nephrotoxicity in rats. Pak J Pharm Sci 2008;21(3): 255-261.
18. Barceloux DG. Cinnamon (Cinnamomum species). Dis Mon 2009;55(6):327-335.
19. Molania T, Moghadamnia AA, Pouramir M, Aghel S, Moslemi D, Ghassemi L, Motallebnejad M. The effect of Cinnamaldehyde on mucositis and salivary antioxidant capacity in gamma-irradiated rats (a preliminary study). DARU J Pharm Sci 2012;20:89-93.
20. Akaro Y, Maruyama H, Mtasumoto K, Ohguchi K, Nishizawa K, Sakamoto T, Araki Y, Mishima S, Nozawa Y. Cell growth inhibitory effect of cinnamic acid derivatives from propolis on human tumor cell lines. Biol Pharm Bull 2003;26:1057-1059.
21. Chen YL, Huang ST, Sun FM, Chiang YL, Chiang CJ, Tsai CM, Weng CJ. Transformation of cinnamic acid from trans- to cis-form raises a notable bactericidal and synergistic activity against multiple-drug resistant Mycobacterium tuberculosis. Eur J Pharm Sci 2011;43:188-194.
22. Naghizadeh B, Boroushaki MT, Mashhadian NV, Mansouri SMT. Protective effects of crocin against cisplatin-induced acute renal failure and oxidative stress in rats. Iran Biomed J 2008;12 (2): 93-100.
23. Fernández-Martínez E, Bobadilla RA, Morales-Ríos MS, Muriel P, Pérez-Álvarez VM. Trans-3-phenyl-2-propenoic acid (cinnamic acid) derivatives: structure-activity relationship as hepatoprotective agents. Med Chem 2007;3(5):475-479.
24. Kasetti RB, Abdul Nabi S, Swapna S, Apparao C. Cinnamic acid as one of the antidiabetic active principle(s) from the seeds of Syzygiumalternifolium. Food Chem Toxicol 2012;50:1425-1431.
25. Institute of Laboratory Animal Resources. Guide for the Care and Use of Laboratory Animals, 8th edition. Washington, D.C.: National Academy Press; 1996.
26. Fawcett JK, Scott JE. A rapid and precise method for the determination of urea. J Clin Path 1960;13:156-159.
27. Bartles H, Bohmer M, Heirli C. Colorimetric kinetic method for creatinine determination in serum and urine. Clin Chem Acta 1972;37:193.
28. Doumas BT, Peters T. Serum and urine albumin: a progress report on their measurement and clinical significance. Clin Chim Acta 1971;31:87-96.
29. Satoh K. Serum lipid peroxides in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978;90:37-43.
30. Beutler E, Duron O, Kelly MB. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882-8.
31. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-126.
32. Nishikimi M, Roa NA, Yogi K. Measurement of superoxide dismutase. Biochem Biophys Res Commun 1972;46:849-854.
33. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-169.
34. Banchroft JD, Stevens A, Turner DR. Theory and practice of histological techniques, 4th edition. New York: Churchil Livingstone; 1996.
35. Kuhad A, Tirkey N, Pilkhwal S, Chopra K. Renoprotective effect of Spirulinafusiformis on cisplatin-induced oxidative stress and renal dysfunction in rats. Ren Fail 2006;28(3):247-254.
36. Naziroglu M, Karaoglu A, Aksoy AO. Selenium and higher dose vitamin E administration protects cisplatin- induced oxidative damage to renal, liver, lens tissues in rats. Toxicology 2004;195: 221-230.
37. Ali BH, Al Moundhri MS, Tag El-din MT, Nemmar A, Tanira MO. The ameliorative effect of cysteine prodrug L-2-oxothiazolidine-4-carboxylic acid on cisplatin-induced nephrotoxicity in rats. Fundam Clin Pharmacol 2007;l21:547-553.
38. Fouad AA, Al-Sultan AI, Refaie SM, Yacoubi MT. Coenzyme Q10 treatment ameliorates acute cisplatin nephrotoxicity in mice. Toxicology 2010;274(1-3):49-56.
39. Yadav YC, Srivastav DN, Seth AK, Saini V, Yadav KS. Nephropharmacological activity of ethanolic extract Lepidium Sativum L. seeds in albino rats using cisplatin induced acute renal failure. Int J Pharm Sci Rev Res 2010;4(3):64-68.
40. ChirinoYI, Sanchez-Gonzalez DJ, Martinez CM, Cruz C, Pedraza-Chaverri J. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology 2008;245:18-23.
41. Lalila A, Ola H, Hossam A, Mohamed M, Sayed A. Effect of cremophor-EL on cisplatin-induced organ toxicity in normal rat. J Egypt Natl Canc Inst 2001;(13):139-145.
42. Boulikas T, Vougiouka M. Cisplatin and platinum drugs at the molecular level. Oncol Rep 2003;10(6):1663-1682.
43. Galea AM, Murray V. The interaction of cisplatin and analogues with DNA in reconstituted chromatin. Biochim Biophys Acta 2002;(2-3):142-152.
44. Dai A, Nie YX, Yu B, Li Q, Lu LY, Bai JG. Cinnamic acid pretreatment enhances heat tolerance of cucumber leaves through modulating antioxidant enzyme activity. Environ Exp Bot 2012;79:1-10.
45. Patra K, Bose S, Sarkar S, Rakshit J, Jana S, Mukherjee A, Roy A, Mandal DP, Bhattacharjee S. Amelioration of cyclophosphamide induced myelosuppression and oxidative stress by cinnamic acid. Chem Biol Interact 2012;195:231-239.
46. Yuan JH, Dieter MP, Bucher JR, Jameson CW. Toxicokinetics of cinnamaldehyde in F344 rats. Food Chem Toxicol 1992;30(12): 997-1004.